Established safety profile

Established safety profile in patients aged 5 to 17 years1



The most frequently reported adverse reactions within the first 12 weeks after BOTOX® 200 Units (not to exceed 6 Units/kg) were bacteriuria (20%), urinary tract infection (UTI [7%]), leukocyturia (7%), and hematuria (3%)

The most common adverse reactions in patients who received BOTOX® 6 Units/kg and less than a total dose of 200 Units were UTI, bacteriuria, and hematuria